SBC Medical Group Holdings Inc (SBCWW)
2025-06-30 | ||||
---|---|---|---|---|
Total revenues, net | 43,358,847 | |||
Cost of revenues (including cost of revenues from related parties of 4,669,602 and 3,616,103 for the three months ended june 30, 2025 and 2024, and 8,126,530 and 5,413,462 for the six months ended june 30, 2025 and 2024, respectively) | 13,348,270 | |||
Gross profit | 30,010,577 | |||
Selling, general and administrative expenses (including selling, general and administrative expenses from related parties of 415,767 and nil for the three months ended june 30, 2025 and 2024, and 415,767 and nil for the six months ended june 30, 2025 and 2024, respectively) | 15,456,385 | |||
Total operating expenses | 15,456,385 | |||
Income from operations | 14,554,192 | |||
Other income | 33,771 | |||
Other expenses | 1,132,465 | |||
Interest income | 22,882 | |||
Interest expense | 49,651 | |||
Gain on disposal of subsidiary | - | |||
Gain on redemption of life insurance policies | - | |||
Change in fair value of cryptocurrencies | 111,632 | |||
Total other income (expenses) | -1,013,831 | |||
Income before income taxes | 13,540,361 | |||
Income tax expense | 11,100,509 | |||
Net income | 2,439,852 | |||
Less net income (loss) attributable to non-controlling interests | -18,388 | |||
Net income attributable to sbc medical group holdings incorporated | 2,458,240 | |||
Net income per share attributable to sbc medical group holdings incorporated - basic | 0.02 | |||
Net income per share attributable to sbc medical group holdings incorporated - diluted | 0.02 | |||
Weighted average shares outstanding - basic | 103,507,249 | |||
Weighted average shares outstanding - diluted | 103,507,249 |